Prostate cancer treatment cost in Turkey

Prostate cancer treatment cost in Turkey by risk group and treatment choice

The right estimate is built after biopsy grade, PSA, clinical stage, MRI, disease extent, age, health, and priorities for urinary and sexual function are reviewed. It should compare active surveillance, prostatectomy, external-beam or internal radiation, hormone treatment, nuclear-medicine options, metastatic medicines, rehabilitation, and PSA follow-up instead of assuming every diagnosis needs robotic surgery.

How much does prostate cancer treatment cost in Turkey?

A radical prostatectomy pathway in Turkey is commonly planned at TRY 376,000 to 846,000 (about USD 8,000 to 18,000), depending on open, laparoscopic, or robotic access, node surgery, admission, and pathology. A complete radiation pathway may require TRY 282,000 to 705,000 (about USD 6,000 to 15,000), while hormone therapy, advanced imaging, radioligand treatment, or prolonged medicines for recurrent or metastatic cancer can raise the total substantially.

USD examples use approximately TRY 47 per USD, close to the official indicative selling rate on 17 July 2026. Robotic consumables, imported medicines, seeds, and nuclear-medicine products may be quoted against EUR or USD; confirm currency, inclusions, schedule, and validity.

Review cost scenarios Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-19

Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team

Billing context: TRY and USD

Risk group comes before treatment

PSA, biopsy grade group, tumor extent, imaging, and life expectancy help separate surveillance, local treatment, and systemic pathways.

Robotic is an approach

Robotic assistance does not replace candidate selection, oncologic technique, surgeon experience, margin and node quality, continence support, or complication rescue.

Radiation has multiple schedules

Conventional, moderately shortened, stereotactic, and brachytherapy plans differ in suitability, equipment, fractions, hormone use, and toxicity.

Follow-up continues after travel

PSA testing, urinary recovery, erectile-function support, hormone effects, bone health, and recurrence assessment require a clear home plan.

Cost at a glance

Planning scenarios for prostate cancer treatment in Turkey

The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.

Estimated prostate cancer treatment cost scenarios in Turkey
Scenario	TRY	USD	Patient and treatment context	Planning scope
Localized prostatectomy pathway	TRY 376,000 - 846,000	USD 8,000 - 18,000	Selected localized or locally advanced disease treated with open, laparoscopic, or robotic radical prostatectomy, with node dissection when indicated.	Should state surgical approach, nerve-sparing intent, node scope, robotic instruments, anesthesia, room, catheter plan, pathology, early PSA review, and complication boundaries.
Definitive radiation pathway	TRY 282,000 - 705,000	USD 6,000 - 15,000	Localized or locally advanced cancer treated with external-beam radiation or a suitable brachytherapy pathway, with hormone treatment when recommended.	Price simulation, imaging, planning, image guidance, every fraction or implant component, reviews, medicines, and follow-up rather than one session.
Advanced or recurrent disease management	TRY 470,000 - 1,880,000+	USD 10,000 - 40,000+	Biochemical recurrence, nodal or distant spread, castration-resistant disease, or symptoms requiring combinations of hormone, targeted, chemotherapy, radiation, or radioligand care.	Use a defined time horizon and named drugs because response, duration, sequencing, molecular eligibility, and toxicity determine continuing cost.

Usually included

Check the clinical package scope

Defined operation

Open, laparoscopic, or robot-assisted prostate removal, stated node dissection, surgeon, anesthesia, theatre, and routine consumables.

Confirm whether robotic instruments and the bedside assistant are included.

Specified admission

Room class, routine medicines, catheter supplies, standard laboratory work, and the number of inpatient days in the quote.

Obtain rates for ICU, extra nights, transfusion, and readmission.

Surgical pathology

Grade, tumor extent, margins, seminal vesicles, nodes, pathologic stage, and routine reporting.

Genomic assays and outside review may be separate.

Early postoperative care

Catheter removal plan, wound review, continence guidance, pathology consultation, and first PSA timing.

Ask how a leak, retention, or delayed catheter removal is billed.

Confirm separately

Charges that may sit outside the range

Advanced imaging and review

Multiparametric MRI, PSMA PET-CT, repeat biopsy, pathology rereview, molecular testing, and cardiac or anesthesia assessment unless named.

Tests should be selected by risk and decision need.

Radiation and hormone treatment

Simulation, planning, fractions, brachytherapy source, androgen-deprivation medicines, administration, and monitoring.

These may be recommended after surgery or instead of it.

Functional rehabilitation

Pelvic-floor physiotherapy, pads, continence devices, erectile rehabilitation, medicines, injections, counseling, or later prosthesis.

Request a realistic recovery and support budget.

Salvage or complication care

Positive-margin review, salvage radiation, bladder-neck treatment, lymphocele drainage, infection, clot, stricture, or readmission.

Keep a reserve beyond the initial package.

Candidate context

Who may be considered and what else may be discussed

Management depends on whether the tumor is clinically significant, its grade group, PSA and PSA pattern, MRI and biopsy extent, TNM stage, PSMA or conventional imaging when appropriate, symptoms, life expectancy, genetic risk, urinary function, prostate size, previous pelvic treatment, heart and metabolic health, and personal views about surveillance, continence, sexual function, and treatment burden. Shared decision-making is essential because several pathways can offer comparable cancer control for selected localized disease while creating different side effects.

Information that shapes suitability

Confirmed diagnosis and grade

Biopsy location, core involvement, grade group, pathology quality, and MRI agreement determine whether more review or sampling is needed.

Risk and stage

PSA, examination, local MRI extent, node risk, and stage-appropriate imaging distinguish active surveillance, local therapy, and systemic care.

Health and life expectancy

Frailty, heart disease, anticoagulation, urinary symptoms, bowel health, previous operations, and realistic longevity alter benefit and risk.

Functional priorities

Baseline continence, erections, fertility wishes, work, travel, caregiving, and willingness for long follow-up should shape the recommendation.

Alternatives or sequencing questions

Active surveillance

Selected low-risk cancers can be monitored with PSA, examination, MRI, and repeat biopsy according to a defined protocol, avoiding or delaying treatment side effects.

Radical prostatectomy

Surgery removes the prostate and provides complete pathology, with approach, node surgery, nerve-sparing, urinary recovery, and salvage options discussed beforehand.

Definitive radiation

External-beam schedules or brachytherapy may treat localized disease, sometimes with hormone therapy according to risk and anatomy.

Systemic and metastasis-directed care

Hormone treatment, chemotherapy, targeted drugs, radioligand therapy, and selected radiation are sequenced according to extent, biology, response, symptoms, and prior therapy.

Procedure variations

Why the named procedure does not have one price

Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.

Robot-assisted prostatectomy

Minimally invasive removal using a robotic platform with reconstruction of the urinary connection.

Ask for surgeon-specific experience and the complete instrument charge.

Open or conventional laparoscopic surgery

Alternative access routes can achieve oncologic surgery in appropriate hands.

Compare outcomes and team capability, not marketing labels.

External-beam radiotherapy

Image-guided treatment may use different total doses and fraction schedules according to risk and anatomy.

Include simulation through final treatment and hormone cost.

Brachytherapy or focal approaches

Internal radiation or focal treatment is suitable only for selected disease, anatomy, urinary function, and institutional expertise.

Clarify evidence, retreatment, surveillance, and salvage implications.

City comparison

Cost and capability by city in Turkey

Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.

Estimated prostate cancer treatment costs and planning context by city in Turkey
City	Local range	USD range	Capability context	Stay planning
Istanbul	TRY 376,000 - 2,115,000+	USD 8,000 - 45,000+	Broad access to robotic urology, radiation, PSMA imaging, nuclear medicine, pathology, and systemic oncology.	Confirm whether every stage of the quoted pathway occurs at one authorized site.
Ankara	TRY 352,500 - 1,880,000+	USD 7,500 - 40,000+	Strong university, public, and private uro-oncology and radiation services.	International self-pay and nuclear-medicine access require hospital confirmation.
Izmir	TRY 329,000 - 1,645,000+	USD 7,000 - 35,000+	Selected tertiary centers offer surgery, radiation, and follow-up pathways.	Verify robot access, surgeon schedule, and PSMA test turnaround.
Antalya	TRY 352,500 - 1,786,000+	USD 7,500 - 38,000+	International coordination is available with center-specific oncology depth.	Separate accommodation bundles from hormone drugs and radiation scope.
Bursa	TRY 305,500 - 1,504,000+	USD 6,500 - 32,000+	Potential value for standard surgical and radiation pathways at qualified centers.	Confirm pathology, continence rehabilitation, and rescue urology.
Kocaeli and Gebze	TRY 329,000 - 1,598,000+	USD 7,000 - 34,000+	Marmara tertiary hospitals can offer access near Istanbul routes.	Calculate repeated radiation travel and catheter follow-up logistics.
Adana	TRY 282,000 - 1,410,000+	USD 6,000 - 30,000+	Regional centers may support standard uro-oncology pathways.	Confirm the proposed surgeon, platform, and radiation service.
Konya	TRY 258,500 - 1,269,000+	USD 5,500 - 27,000+	Selected programs may offer value for well-defined localized treatment.	Advanced imaging and salvage capability must be checked.
Kayseri	TRY 258,500 - 1,269,000+	USD 5,500 - 27,000+	Tertiary review may be available for surgery and standard oncology.	Plan urinary support and flight timing after catheter removal.
Gaziantep	TRY 235,000 - 1,175,000+	USD 5,000 - 25,000+	Hospital-level verification is essential for robotics, PSMA services, and advanced therapy.	A lower headline price should not fragment staging and follow-up.

Estimate variables

What can change the final hospital cost

Risk group and disease extent

Low-risk localized, high-risk local, node-positive, recurrent, and metastatic disease have different goals and durations.

Require the risk group and stage in the written plan.

Surgical approach and node scope

Platform fees, instruments, node dissection, anatomy, prior surgery, and admission alter prostatectomy cost.

Nerve-sparing intent is not a guaranteed functional outcome.

Radiation schedule and technology

Fraction number, field, image guidance, brachytherapy, rectal protection, and hormone duration change the total.

Compare complete courses with the same indication.

Systemic medicine horizon

Hormone injections, oral androgen-pathway drugs, chemotherapy, targeted therapy, and radioligand treatment vary by month and cycle.

Price to a defined reassessment point.

Recovery and salvage needs

Continence therapy, erectile support, stricture treatment, or additional radiation after recurrence can exceed the original travel window.

Include long-term home costs in the decision.

Medical cost breakdown

Before admission, in hospital, and after discharge

Diagnostics and preparation

Pathology review

Biopsy cores, grade group, tumor amount, special findings, and expert rereview when results or treatment implications are uncertain.

Send slide maps and original reports.

Local assessment

PSA history, examination, multiparametric MRI, targeted or systematic biopsy details, urinary evaluation, and selected cystoscopy.

MRI should be reviewed with biopsy location.

Stage and biology

PSMA PET-CT or conventional imaging when indicated, plus germline or tumor testing for selected high-risk, recurrent, or metastatic disease.

Not every low-risk diagnosis needs advanced imaging.

Admission and treatment

Prostatectomy admission

Surgical and anesthesia team, platform and instruments where applicable, room, catheter, pathology, medicines, and routine postoperative tests.

Ask about lymphocele, leak, transfusion, and extra-day billing.

Radiation delivery

Consultation, simulation, planning images, physics, image guidance, all fractions or source charges, and on-treatment reviews.

Include required hormone treatment separately.

Systemic or nuclear-medicine treatment

Drug or radiopharmaceutical, preparation, administration, laboratory and imaging checks, radiation-safety instructions, and toxicity support.

Confirm eligibility and local licensing before travel.

Recovery and follow-up

Urinary recovery

Catheter care, pelvic-floor therapy, pads, medications, testing, and treatment if leakage or obstruction persists.

Recovery varies and cannot be guaranteed by a package.

Sexual and fertility care

Counseling, sperm storage before treatment where relevant, rehabilitation medicines, devices, injections, or later procedures.

Discuss baseline function and realistic goals before treatment.

Hormone and bone-health monitoring

Metabolic, heart, mood, hot-flush, muscle, and bone assessment during prolonged androgen suppression.

Coordinate monitoring with the home physician.

PSA surveillance

Post-treatment PSA pattern, clinical review, imaging when indicated, and early salvage discussion for concerning results.

Obtain thresholds and timing in writing.

Complete journey budget

Plan beyond the hospital invoice

Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.

Treatment-specific stay

Surgery requires perioperative recovery, while radiation may need repeated daily attendance and systemic care may span months.

Decide which phases can safely transfer home.

Catheter and mobility logistics

Accommodation near urology, supplies, companion support, transport, and flexible flights while continence and catheter status change.

Do not fly until the treating team confirms readiness.

Extended-care reserve

Urine leak, infection, retention, bleeding, lymphocele, changed pathology, extra radiation, or delayed recovery can add days and treatment.

Ask who authorizes and prices unexpected care.

Country access

Rules and practical requirements to verify

Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.

Check authorized-provider status

Use the current Turkish Ministry of Health international-health-tourism list and verify that the operation, radiation, or nuclear-medicine service is delivered at the named facility.

Confirm device and medicine terms

Robotic consumables, hormone drugs, radiopharmaceuticals, and imported products should be named with billing currency and procurement conditions.

Verify radiation and nuclear services

Ask about current authorization, specialist staffing, equipment, quality assurance, radiation-safety process, and interruption arrangements.

Protect pathology and data continuity

Clarify release and return of slides, blocks, MRI and PET DICOM, operation video if offered, and English discharge records.

Use official visa guidance

Check the Turkish government e-Visa portal or relevant mission for nationality-specific entry rules and allow flexibility for clinical changes.

Hospital selection

Compare capability before package price

Uro-oncology multidisciplinary review

Urologic oncologist, radiation oncologist, medical oncologist, radiologist, pathologist, nuclear medicine, genetics, and rehabilitation as relevant.

Ask whether alternatives are discussed before booking.

Approach-specific experience

Surgeon case profile for the proposed open, laparoscopic, or robotic procedure and planned node dissection.

Ask for definitions behind margin and continence outcomes.

Radiation and imaging capability

Prostate MRI, PSMA imaging where appropriate, planning, image guidance, brachytherapy if offered, and physics quality assurance.

A machine brand alone is insufficient.

Functional recovery program

Pelvic-floor, continence, sexual-health, catheter, infection, stricture, and psychosocial support.

Confirm support after hotel discharge and after return home.

Advanced-disease continuity

Medical oncology, molecular testing, pharmacy, bone care, nuclear medicine, pain management, and emergency access.

Prolonged treatment should not depend on one overseas trip.

Treating team

Specialists and support that may matter

Urologic oncologist

Assesses surveillance and surgical options, resection approach, node need, nerve-sparing intent, urinary reconstruction, and complication management.

Radiation oncologist

Recommends external-beam or internal radiation, dose and fractions, image guidance, organ protection, and hormone-treatment integration.

Medical oncologist

Sequences hormone therapy, chemotherapy, targeted treatment, bone support, and other medicines for advanced or recurrent disease.

Genitourinary pathologist and radiologist

Confirm grade, extent, MRI-biopsy agreement, stage, postoperative features, and the meaning of recurrent-disease imaging.

Continence and sexual-health team

Establish baseline function, teach pelvic-floor care, support rehabilitation, and escalate persistent urinary or sexual problems.

Treatment timeline

From report review to return-home follow-up

Remote risk review

Share PSA history, biopsy and slides, MRI and other imaging, urinary and sexual baseline, illnesses, medicines, and treatment priorities.

Arrival confirmation

Resolve pathology or stage uncertainty and complete only testing that changes surveillance, surgery, radiation, or systemic decisions.

Options consultation

Compare cancer control, side effects, time, salvage possibilities, cost, and home follow-up across reasonable pathways.

Treatment phase

Proceed with surveillance enrollment, surgery, radiation, hormone therapy, or a combined pathway according to the final plan.

Recovery and response assessment

Review pathology or treatment completion, catheter and urinary recovery, side effects, PSA timing, and any adjuvant or salvage trigger.

Home continuity

Transfer pathology, operation or radiation details, medicines, rehabilitation, PSA schedule, imaging criteria, and urgent contact instructions.

Risks and edge cases

Events that can change the plan, stay, or cost

Pathology upgrade or stage change

Expert review, surgery, or advanced imaging may reveal higher-risk or more extensive disease than initially reported.

Revisit treatment and budget before proceeding.

Urinary leak, retention, or lymphocele

Longer catheterization, imaging, drainage, antibiotics, or readmission may delay travel.

Ask for out-of-package rates and support contact.

Persistent incontinence or stricture

Longer rehabilitation, testing, medication, endoscopic care, or a later continence procedure may be needed.

No ethical provider can guarantee immediate pad-free recovery.

Radiation urinary or bowel toxicity

Frequency, burning, bleeding, bowel changes, fatigue, or late effects can require treatment after return home.

Carry the dose and field summary.

Hormone-treatment complications

Metabolic, cardiovascular, bone, mood, sexual, and muscle effects need prevention and monitoring.

Coordinate long-duration care locally.

Destination comparison

Compare India, Turkey, and Thailand for this procedure

The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.

Procedure planning comparison across India, Turkey, and Thailand
Decision factor	India	Turkey	Thailand	How to use this
Robotic surgery access	Available at major metro programs with variable package and instrument pricing.	Broad access in major private and academic centers, particularly Istanbul and Ankara.	Available in leading private hospitals with potentially higher facility costs.	Compare surgeon experience, scope, pathology, rescue, and rehabilitation.
Radiation choices	Wide access with center-specific stereotactic and brachytherapy expertise.	Modern image-guided platforms and selected brachytherapy programs are available.	Advanced radiation is concentrated in major urban centers.	Candidate fit and complete course matter more than platform labels.
PSMA and advanced therapy	Expanding imaging and nuclear-medicine access at specialist centers.	Major programs offer advanced imaging and selected nuclear-medicine pathways.	Availability requires center-specific confirmation and may be costly.	Verify indication, product, licensing, schedule, and follow-up.
Recovery continuity	Large specialist pool, but travel distance may affect repeat visits.	Convenient for many European, Middle Eastern, and Central Asian patients.	Long travel can complicate catheter or radiation follow-up.	Choose the destination with a credible home-care bridge.

Decision guidance

When Turkey may fit and when to keep comparing

Turkey may fit when

A verified program confirms grade and stage, compares surveillance, surgery, and radiation fairly, and provides functional rehabilitation and PSA handover.

Keep comparing when

Robotic surgery is sold before pathology review, the quote omits node or instrument charges, or a radiation estimate counts only one fraction.

Request another opinion when

Recommendations conflict on surveillance eligibility, nerve-sparing, node dissection, radiation plus hormone treatment, recurrence imaging, or advanced medicine.

Seek urgent local care when

There is inability to pass urine, heavy bleeding, chest pain, breathing difficulty, fever after a procedure, severe weakness, confusion, or uncontrolled pain.

Reports for review

Prepare a case file before requesting estimates

Create a chronological file containing the original biopsy, PSA history, MRI and stage imaging, urinary and sexual baseline, prior prostate procedures, medicines, and health conditions. Share DICOM studies and pathology material where allowed so treatment is not selected from a brief report alone.

Upload medical reports

Diagnosis and risk

Biopsy report and map

Provide grade group, cores involved, percentage or length, sites, special findings, and date.

Slides or blocks

State whether material can be released for expert review and molecular work.

PSA chronology

List dated PSA values, infection or instrumentation context, and relevant medicines.

Genetic and family history

Include prior germline or tumor testing and prostate, breast, ovarian, pancreatic, or related family cancers.

Imaging and function

Prostate MRI

Send DICOM images and report with lesion score, location, capsule, seminal vesicle, and node findings.

Stage imaging

Provide PSMA PET-CT, CT, bone scan, or other studies with dates and source files.

Urinary baseline

Describe flow, frequency, retention, infections, pads, prostate medicines, and prior procedures.

Sexual and fertility baseline

Record erections, treatments, fertility wishes, and preservation discussions.

Safety and planning

Health and anesthesia records

Include heart, lung, kidney, diabetes, anticoagulation, allergies, operations, and recent laboratory results.

Prior cancer treatment

List prostate or pelvic surgery, radiation, hormone therapy, chemotherapy, and response.

Goals and preferences

State priorities around surveillance, cancer control, urinary and sexual function, time, and travel.

Home follow-up access

Add the home urologist, oncologist, laboratory, rehabilitation, and emergency contacts.

Common questions

Questions about cost, travel, and follow-up

Does every prostate cancer need immediate treatment?

No. Selected low-risk disease may be monitored with structured active surveillance after pathology, imaging, health, life expectancy, and patient preferences are reviewed.

How much is robotic prostate surgery in Turkey?

A broad planning range is about TRY 376,000 to 846,000, or USD 8,000 to 18,000, but approach, node surgery, robotic instruments, admission, pathology, and complications determine the written quote.

Is robotic surgery better than radiation?

Neither is universally better. Risk group, anatomy, urinary and bowel function, health, side-effect priorities, time, and available salvage options guide the choice.

Will nerve-sparing prevent erectile dysfunction?

It may support recovery in suitable cases, but age, baseline function, cancer location, one- or two-sided preservation, healing, and additional treatment affect results.

How long is a radiation course?

The schedule can range from a few highly focused treatments to several weeks, while brachytherapy follows another pathway. The radiation oncologist must determine suitability and fractions.

Are hormone injections included in radiation cost?

Only if the estimate names the medicine, dose, administration dates, planned duration, monitoring, and management of bone, metabolic, heart, and sexual effects.

When can I fly after prostatectomy?

The surgeon should confirm based on catheter status, urine leak, bleeding, infection, mobility, clot risk, pain control, and travel duration rather than a package timetable.

What happens if PSA rises after treatment?

The team reviews the PSA pattern, pathology, prior treatment, symptoms, and appropriate imaging before recommending surveillance, salvage radiation, systemic treatment, or another pathway.

Should I get a PSMA PET-CT before treatment?

It can be useful in selected risk groups or recurrence settings, but it is not automatically necessary for every newly diagnosed low-risk cancer.

What records do I need after returning home?

Carry pathology, stage, operation or radiation details, medicines, catheter and rehabilitation plan, complications, PSA timing, imaging criteria, and clinician contacts.

Review and sources

How this guide was prepared

Ranges were built for three distinct decisions: localized surgery, definitive radiation, and recurrent or advanced management. Turkey market figures were normalized near the 17 July 2026 exchange rate and expanded to include staging, approach-specific consumables, pathology, node scope, complete radiation delivery, hormone or advanced medicines, functional rehabilitation, and surveillance. NCI materials inform the risk-led clinical structure, while Turkish Ministry resources support provider and service verification. These are planning bands rather than guaranteed charges.

This guide is educational and cannot determine cancer significance, risk group, surveillance eligibility, surgical or radiation choice, prognosis, medicine eligibility, or travel safety. Use expert pathology, appropriate imaging, shared multidisciplinary review, and a current written quotation. Inability to pass urine, heavy bleeding, chest pain, breathing difficulty, fever after a procedure, confusion, severe weakness, or uncontrolled pain requires urgent local assessment.

Related planning